Does Molina Healthcare Cover Vyvanse?
The verdict
Covered on most plans
Molina Healthcare covers Vyvanse (lisdexamfetamine) for two FDA-approved indications — ADHD and adult binge-eating disorder — with prior authorization on its Medicaid and Marketplace plans. Generic lisdexamfetamine is the preferred formulary option; brand Vyvanse is non-preferred. Molina's CNS-stimulant PA rule permits only one stimulant at a time and requires a documented diagnosis. A 70 mg/day quantity limit applies. Molina has minimal commercial/employer business — Medicaid and Marketplace are the primary lines of business.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Molina Healthcare using your member ID.
Medicare vs. commercial coverage
Whether Molina Healthcare covers Vyvanse depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Part D (select Molina Medicare Advantage-PD plans): generic lisdexamfetamine is covered with a Schedule II quantity limit of 70 mg/day; brand Vyvanse may require prior authorization. Molina's Medicare Advantage presence is more limited than its Medicaid book — verify whether your specific Molina MA-PD plan covers lisdexamfetamine on its plan drug list.
Commercial / Employer
Group & marketplace plans
Molina has minimal to no commercial/employer book. ACA/Marketplace (Molina's key non-Medicaid LOB): generic lisdexamfetamine is covered with PA and a 70 mg/day quantity limit; brand Vyvanse is non-preferred. Molina's CNS-stimulant PA criteria require documentation of ADHD or adult binge-eating disorder and allow only one stimulant at a time. Medicaid (Molina's core book): generic lisdexamfetamine covered per state PDL with PA, 70 mg/day QL, and the one-stimulant-at-a-time rule; nominal cost-share. Shortage-documented PA or pharmacist override can support brand dispensing when generic is unavailable.
The 5 boxes you must tick to get approved
Commercial plans that will consider Vyvanse require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
0 of 5 requirements selected. Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Vyvanse actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Brand Vyvanse: approx. $400–$558/month (Takeda list price, estimate). Generic lisdexamfetamine: approx. $200–$360/month cash, as low as approx. $60–$70 with a coupon.
List price with no coverage — before any manufacturer savings card.
With coverage
Medicaid: nominal cost-share (typically $0–$4) for covered generic lisdexamfetamine after PA approval. ACA/Marketplace: plan-specific copay or coinsurance — verify on your Molina Marketplace plan formulary. Brand Vyvanse: non-preferred tier (higher cost-share); verify on plan formulary.
Typical monthly copay once prior authorization is approved.
All cost figures are estimates. Actual cost-share depends on your specific Molina plan, benefit design, and state Medicaid rules. Verify current copays on the Molina member portal or by calling member services. Medicaid and Marketplace cost-shares are distinct — confirm which LOB applies to your plan.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Check the Molina member portal or plan drug list
Log in to your Molina member account at molinahealthcare.com and use the drug lookup tool. Search for 'lisdexamfetamine' (generic) and 'Vyvanse' (brand) to confirm current tier, PA requirements, and quantity limits for your specific state plan.
- 2
Call Molina member services
Call the number on the back of your Molina insurance card and ask: (1) Is generic lisdexamfetamine covered on my plan with PA? (2) What is the one-stimulant-at-a-time rule for my plan? (3) Is the quantity limit 70 mg/day? (4) What diagnosis documentation is needed for prior authorization?
- 3
Have your prescriber submit the prior authorization
Your prescriber must submit PA documentation including the ADHD or binge-eating disorder diagnosis, the prescribed dose (within the 70 mg/day QL), and confirmation that no other stimulant is currently active on your plan. For brand Vyvanse, also document generic unavailability. Medicaid PA routing goes through the Molina PA portal — confirm the process with your prescriber's office.
Options if Molina Healthcare won't cover Vyvanse
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Generic lisdexamfetamine
The preferred, lowest-cost formulary option. FDA-approved August 2023. Identical active ingredient to brand Vyvanse. Cash price approx. $200–$360/month; as low as approx. $60–$70 with coupon. Verify pharmacy availability — intermittent shortage continues.
Generic amphetamine/dextroamphetamine (Adderall generic)
Covered on Molina plans for ADHD. Different chemical from lisdexamfetamine; not FDA-approved for binge-eating disorder. Cash price approx. $17–$55/30 days. Molina's one-stimulant-at-a-time rule applies — cannot be combined with Vyvanse/lisdexamfetamine.
Methylphenidate generics (e.g., Ritalin generic, Concerta generic)
Typically covered on Molina Medicaid formularies for ADHD. A different stimulant class from amphetamines. Molina's one-stimulant-at-a-time PA rule means methylphenidate cannot be co-prescribed with lisdexamfetamine.
These options are listed for information only — your own clinician decides what is appropriate for you.
Frequently Asked Questions
Yes — Molina's documented Vyvanse/lisdexamfetamine coverage includes both ADHD and adult binge-eating disorder as covered diagnoses for prior authorization. This is a Vyvanse-specific indication; Adderall (amphetamine/dextroamphetamine) is not FDA-approved for binge-eating disorder. Prior authorization with documented BED diagnosis is required. Verify BED coverage on your specific Molina state plan, as Medicaid PDLs can vary by state.
Molina's CNS-stimulant prior authorization criteria allow only one stimulant medication at a time for a covered member. If you are currently prescribed another stimulant (amphetamine salts, methylphenidate, or others), you must discontinue it before Molina will authorize lisdexamfetamine/Vyvanse. This rule applies on Medicaid and Marketplace plans and is designed to prevent concurrent stimulant use. Discuss with your prescriber before switching.
Molina applies a maximum of 70 mg per day for lisdexamfetamine (Vyvanse/generic), consistent with FEP-standard criteria (CVS Caremark Policy 5.60.024, eff. April 1, 2026). No automatic refills are permitted; Schedule II prescriptions require a new written or electronic prescription for each fill. State Medicaid PDLs may apply their own quantity limits — verify on your state's PDL.
Molina's formularies prefer generic lisdexamfetamine (FDA-approved August 2023) over brand Vyvanse. Brand Vyvanse is non-preferred and typically requires a formulary exception or shortage-documented PA. During 2024, some plans temporarily added brand Vyvanse back due to generic supply constraints; those add-backs are now being reversed as generic supply improves. If your pharmacy cannot fill the generic, document the shortage and ask your prescriber to request brand coverage.
Molina Medicaid plans cover generic lisdexamfetamine for ADHD and adult binge-eating disorder with prior authorization and a 70 mg/day quantity limit, per state PDL. Brand Vyvanse is non-preferred. Molina operates Medicaid managed care in multiple states, and PDL criteria vary — the one-stimulant-at-a-time rule and PA documentation requirements apply broadly, but verify your specific state plan's coverage details through Molina member services or the state Medicaid PDL.
Related Articles
Does Molina Healthcare Cover Wegovy? 2026 State Guide | Curex
Molina covers Wegovy for obesity only in the 13 states with Medicaid GLP-1 coverage as of 2026. Most Molina states exclude it. Check your state PDL.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Molina Healthcare Cover Mounjaro? 2026 | Curex
Molina Healthcare covers Mounjaro for T2D at $0-$4 Medicaid copay with prior auth — not weight loss. GLP-1s for obesity are excluded in most Molina states.
Read moreDoes EmblemHealth Cover Ozempic? 2026 Coverage Guide | Curex
EmblemHealth covers Ozempic for type 2 diabetes with prior auth — not weight loss. Verify on plan lookup. NovoCare $25/fill for commercial T2D patients.
Read moreDoes Wellcare Cover Farxiga? Coverage & Cost 2026
Yes — Wellcare covers Farxiga on Part D and Medicaid plans. IRA price $178.50. Medicaid requires metformin-first step. 5-tier structure, $615 deductible.
Read moreDoes Cigna Cover Vyvanse? 2026
Cigna covers Vyvanse — generic lisdexamfetamine preferred via Express Scripts; brand non-preferred. 70 mg/day QL. Verify tier on your Cigna plan.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Molina Healthcare before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.